SEELY LYNN received a stock award from LYELL IMMUNOPHARMA, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/26/2025ACC: 0001415889-25-005768
+1.86M
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
1.86M acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+337.50K
Price / share
—
Trade value
—
% of position
168.8%
2/10/2025
200K→537.50K
Total
Net shares
+337.50K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/10/2025 | A · Award | +337.50K | — | — | 168.8% | 200K | 537.50K |
| Total | +337.50K | $0.00 | ||||||
Derivative Transactions2
Option (right to buy)
Direct
Converts to
Common Stock
1.35M shares
Shares
+1.35M
Strike price
0.5535
Held after
1.35M
Exercisable
—
2/10/2025
Option (right to buy)
Direct
Converts to
Common Stock
168.75K shares
Shares
+168.75K
Strike price
0.5535
Held after
168.75K
Exercisable
—
2/10/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Option (right to buy) Direct | Common Stock1.35M shares | 2/10/2025 | A · Award | +1.35M | 0.5535 | — | 1.35M |
| Option (right to buy) Direct | Common Stock168.75K shares | 2/10/2025 | A · Award | +168.75K | 0.5535 | — | 168.75K |